Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer
This study has been completed.
Study NCT00050141   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: November 22, 2002   Last Updated: November 20, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
ZARNESTRA, tipifarnib, R115777
Additional drug interventions recognized in this trial
Estrogen Antagonists
Estrogen Receptor Modulators
Letrozole
Tipifarnib
More general drug interventions related to this trial
Antineoplastic Agents
Aromatase Inhibitors
Enzyme Inhibitors
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services